PF-02545920
Sponsors
Pfizer
Conditions
HealthyHuntington's DiseaseSchizo-affective DisorderSchizophrenia
Phase 1
Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia
CompletedNCT00463372
Start: 2006-10-31End: 2007-05-31Target: 40Updated: 2018-09-05
Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects
CompletedNCT01103726
Start: 2010-05-31End: 2011-11-30Updated: 2011-11-16
Effects Of PF-02545920 On Ketamine-Induced Abnormal Prefrontal Brain Response To Associative Learning In Healthy Subjects
TerminatedNCT01244880
Start: 2011-04-30End: 2012-08-31Updated: 2014-03-21
A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia
CompletedNCT01829048
Start: 2013-03-06End: 2013-10-17Updated: 2018-08-20
A Study To Evaluate The PDE10 Enzyme Occupancy Following A Single Dose Of PF-02545920 In Healthy Male Volunteers
CompletedNCT01918202
Start: 2014-03-31End: 2014-09-30Updated: 2014-11-10
Phase 2
Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo
TerminatedNCT00570063
Start: 2007-11-30End: 2008-02-18Updated: 2017-12-20
An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia
CompletedNCT01175135
Start: 2010-10-31End: 2011-08-31Updated: 2018-05-22
Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease
CompletedNCT01806896
Start: 2013-09-30End: 2015-01-31Updated: 2017-12-14
An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia
TerminatedNCT01939548
Start: 2013-10-31End: 2014-10-31Updated: 2016-08-22
Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease
CompletedNCT02197130
Start: 2014-09-30End: 2016-10-31Updated: 2017-11-17